Corporation Science Park, Taras Shevchenko University of Kyiv, 60 Volodymyrska Str., Kyiv, 01033, Ukraine.
Institute of High Technologies, Taras Shevchenko National University of Kyiv, Volodymyrska Street, 64, Kyiv, 01601, Ukraine.
Sci Rep. 2023 Jun 8;13(1):9306. doi: 10.1038/s41598-023-36496-4.
Here, a comparative toxicity assessment of precursor carbon dots from coffee waste (cofCDs) obtained using green chemistry principles and Gd-doped nanohybrids (cofNHs) was performed using hematological, biochemical, histopathological assays in vivo (CD1 mice, intraperitoneal administration, 14 days), and neurochemical approach in vitro (rat cortex nerve terminals, synaptosomes). Serum biochemistry data revealed similar changes in cofCDs and cofNHs-treated groups, i.e. no changes in liver enzymes' activities and creatinine, but decreased urea and total protein values. Hematology data demonstrated increased lymphocytes and concomitantly decreased granulocytes in both groups, which could evidence inflammatory processes in the organism and was confirmed by liver histopathology; decreased red blood cell-associated parameters and platelet count, and increased mean platelet volume, which might indicate concerns with platelet maturation and was confirmed by spleen histopathology. So, relative safety of both cofCDs and cofNHs for kidney, liver and spleen was shown, whereas there were concerns about platelet maturation and erythropoiesis. In acute neurotoxicity study, cofCDs and cofNHs (0.01 mg/ml) did not affect the extracellular level of L-[C]glutamate and [H]GABA in nerve terminal preparations. Therefore, cofNHs demonstrated minimal changes in serum biochemistry and hematology assays, had no acute neurotoxicity signs, and can be considered as perspective biocompatible non-toxic theragnostic agent.
在此,我们采用体内(CD1 小鼠,腹腔注射,14 天)血液学、生物化学、组织病理学检测和体外(大鼠皮质神经末梢、突触体)神经化学方法,对基于绿色化学原理制备的咖啡废料前体碳点(cofCDs)和掺钆纳米杂化材料(cofNHs)进行了比较毒性评估。血清生化数据显示 cofCDs 和 cofNHs 处理组有相似的变化,即肝酶活性和肌酐没有变化,但尿素和总蛋白值降低。血液学数据表明,两组的淋巴细胞均增加,同时粒细胞减少,这可能表明机体存在炎症过程,并通过肝脏组织病理学得到证实;红细胞相关参数和血小板计数降低,平均血小板体积增加,这可能表明血小板成熟存在问题,并通过脾脏组织病理学得到证实。因此,cofCDs 和 cofNHs 对肾脏、肝脏和脾脏相对安全,但对血小板成熟和红细胞生成存在担忧。在急性神经毒性研究中,cofCDs 和 cofNHs(0.01mg/ml)均未影响神经末梢制剂中 L-[C]谷氨酸和[H]GABA 的细胞外水平。因此,cofNHs 在血清生化和血液学检测中仅有微小变化,没有急性神经毒性迹象,可被视为有前景的生物相容无毒治疗剂。
Natl Toxicol Program Tech Rep Ser. 1994-12
Natl Toxicol Program Tech Rep Ser. 1993-9
J Ethnopharmacol. 2013-12-31
Natl Toxicol Program Tech Rep Ser. 1997-5
Natl Toxicol Program Tech Rep Ser. 1994-2
Natl Toxicol Program Tech Rep Ser. 1994-12
Environ Toxicol Pharmacol. 2015-1-5
Natl Toxicol Program Tech Rep Ser. 1997-4
Molecules. 2021-12-10
Clin Mol Hepatol. 2022-1
Sci Total Environ. 2021-12-15
Anal Methods. 2021-6-7